Specialized palliative care in patients with haematological malignancies receiving chimeric antigen receptor T-cell therapy

Br J Haematol. 2024 Jul;205(1):343-346. doi: 10.1111/bjh.19434. Epub 2024 Mar 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Female
  • Hematologic Neoplasms* / therapy
  • Humans
  • Immunotherapy, Adoptive* / adverse effects
  • Immunotherapy, Adoptive* / methods
  • Male
  • Middle Aged
  • Palliative Care* / methods
  • Receptors, Chimeric Antigen* / therapeutic use

Substances

  • Receptors, Chimeric Antigen